Temple Robert K

Robert K Temple sells 127.9K SMR shares (98.5% of holdings) for $2.3M at $18.20–$19.14, retaining only 2.0K shares

Robert K Temple executed two separate sales totaling 127,920 shares for $2,339,495.25, reducing his stake from 129,920 shares to just 2,000 shares—a near-complete exit. The sales occurred at $18.20 on 2024-10-16 and $19.14 on 2024-10-17, near the stock's 52-week high of $19.07 and well above its 90-day surge of +61.2%. His prior three sales at SMR (2024-09-20, 2024-08-14, 2024-08-13) produced negative 30-day returns of -14.0% and -3.2% on measurable outcomes, establishing a pattern of sales that precede near-term declines at this ticker. The company remains unprofitable ($-27.6M net income) despite strong revenue growth of +93.2%, creating fundamental risk that may explain the liquidation timing near a 52-week peak.

Temple Robert K sells 144,627 shares (91.1% of holdings) at $10.90 amid 30-day +37.8% run and unprofitable fundamentals.

Temple Robert K executed a substantial reduction, selling 144,627 shares (144.6K shares) at $10.90, leaving only 14,054 shares post-transaction. The timing coincides with a strong 30-day rally of +37.8%, though the stock trades 24.4% below its 52-week high of $15.81. NuScale remains unprofitable with net income of $-27,617,000.00 ($-27.6M) in its most recent full fiscal year, despite revenue growth of +93.2% year-over-year. The insider's prior two sales at this same ticker (both in August 2024) showed modest negative returns over 30 days (-3.2% and -14.0%), establishing a pattern of selling activity at this specific security.

NuScale CFO Robert K Temple sold 100,000 shares (84.0% of holdings) for $1,001,550.00 at $10.02–$10.03, stock now $9.38 (-40.7% from 52-week high)

Robert K Temple sold 100,000 shares across two transactions at $10.03 on 2024-08-13 and $10.00 on 2024-08-14, reducing his holdings from 119,054 to 19,054 shares—an 84.0% reduction. The sale occurred in a high-volatility environment: while the 90-day change shows +48.6%, the stock is down 40.7% from its 52-week high of $15.81 and down 39.7% over the past 30 days, indicating significant momentum loss near the time of the sale. The company remains unprofitable with net income of $-27,617,000.00 against quarterly revenue of $967,000.00, though annual revenue growth is positive at +93.2%. The combination of a near-complete exit by a senior executive (leaving 19.1K shares) at a price point that now appears ~6% above current market value, coupled with the company's persistent losses and recent sharp price decline, creates a material signal warranting investor attention.